Robuta

Despite considerable efforts to develop efficient carriers, the major target organ of short-interfering RNAs (siRNAs) remains limited to the liver. Expanding...

SigmaMab Antibody Drug Conjugate Mimic, is a non-toxic drug mimic utilized as a standard for mass spectrometry and high performance liquid chromatography.

YUMAB is a world leading provider of contract research, technologies, and R&D services for the development of fully human, therapeutic antibodies.

Nanjing, China--(Newsfile Corp. - January 15, 2026) - Nanjing Leads Biolabs Co., Ltd. (HKE: 9887) ("Leads Biolabs" or the "Company")...

ANTIBODY ENGINEERING & THERAPEUTICS ASIA | THE ONLY CONFERENCE IN ASIA PROVIDING THE LATEST SCIENCE, TECHNOLOGY AND PARTNERS TO ACCELERATE ANTIBODY & PROTEIN...

The opponent, Prof. Jonathan Sleeman from the University of Heidelberg, appeared to be very versed and comfortable in the Finnish Ph.D. thesis defense culture.

Our publication from eLIFE was featured in the in-press section of the Finnish medical journal Duodecim

Phage display technology has played a key role in the remarkable progress of discovering and optimizing antibodies for diverse applications, particularly...

Overexpression of epidermal growth factor receptor (EGFr) has been demonstrated on many human tumors, and the increase in receptor expression levels has been...

scientific article published in May 1972

Services and Resources

A new review about Lymphatic Vessels in Regenerative Medicine and Tissue Engineering

Kyungdong Pharmaceutical announced on the 11th that it has been selected for the project "Development of Formulation and Manufacturing Technology for H...

CD47 is a widely expressed cell surface protein that functions as a regulator of phagocytosis mediated by cells of the innate immune system, such as...

Explore the latest tools that boost speed and accuracy in B-cell cloning processes.

The rise of antimicrobial-resistant bacterial infections is a crucial health concern in the 21st century. In particular, antibiotic-resistant Pseudomonas aer...

BackgroundMature T-cell neoplasms arise from the neoplastic transformation of a single T lymphocyte, and all cells in a neoplastic clone share the same V seg...

Thermo Fisher Scientific Custom Antibody Development offers customized production of monoclonal and polyclonal antibodies with peptide design and project...

Precision Antibody to Showcase Expertise in Biomarker Antibody Development at the 20 Drug Discovery. Precision Antibody, a leader in custom monoclonal antibody...

People working in Lymphangiogenesis Research and Antibody Development group.

Antibody-based therapies are a promising treatment option for managing ebolavirus infections. Several Ebola virus (EBOV)-specific and, more recently,...

Zenas BioPharma and BMS have signed an agreement for the development and commercialisation of obexelimab to treat autoimmune ailments.

Pathological antibodies, Tag antibodies,Internal control antibodies,Signal transduction antibodies,Peptide antigen library, Antibody services

Scientists have identified how a kind of immature immune cell responds to a part of influenza virus and have traced the path those cells take to generate...